<SEC-DOCUMENT>0001477932-25-000517.txt : 20250129
<SEC-HEADER>0001477932-25-000517.hdr.sgml : 20250129
<ACCEPTANCE-DATETIME>20250129164513
ACCESSION NUMBER:		0001477932-25-000517
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250129
DATE AS OF CHANGE:		20250129

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cosmos Health Inc.
		CENTRAL INDEX KEY:			0001474167
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				270611758
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-86294
		FILM NUMBER:		25569978

	BUSINESS ADDRESS:	
		STREET 1:		5 AGIOU GEORGIOU, PILEA
		CITY:			THESSALONIKI
		STATE:			J3
		ZIP:			55438
		BUSINESS PHONE:		312-536-3102

	MAIL ADDRESS:	
		STREET 1:		5 AGIOU GEORGIOU, PILEA
		CITY:			THESSALONIKI
		STATE:			J3
		ZIP:			55438

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cosmos Holdings Inc.
		DATE OF NAME CHANGE:	20140106

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIME ESTATES & DEVELOPMENTS INC
		DATE OF NAME CHANGE:	20091008

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Siokas Grigorios
		CENTRAL INDEX KEY:			0001660125
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	MAIL ADDRESS:	
		STREET 1:		5 AG. GEORGIOU STR., PILEA
		CITY:			THESSALONIKI
		STATE:			J3
		ZIP:			TK57001
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <previousAccessionNumber>0001477932-22-005644</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001660125</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>3</amendmentNo>
      <securitiesClassTitle>Common Stock, Par Value $0.001 per share</securitiesClassTitle>
      <dateOfEvent>01/14/2025</dateOfEvent>
      <previouslyFiledFlag>true</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001474167</issuerCIK>
        <issuerCUSIP>221413206</issuerCUSIP>
        <issuerName>Cosmos Health Inc.</issuerName>
        <address>
          <com:street1>5 AGIOU GEORGIOU, PILEA</com:street1>
          <com:street2>5 AGIOU GEORGIOU, PILEA</com:street2>
          <com:city>THESSALONIKI</com:city>
          <com:stateOrCountry>J3</com:stateOrCountry>
          <com:zipCode>55438</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Elliot H. Lutzker</personName>
          <personPhoneNum>646-428-3210</personPhoneNum>
          <personAddress>
            <com:street1>605 Third Ave</com:street1>
            <com:street2>34th Floor</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10158</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001660125</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Siokas Grigorios</reportingPersonName>
        <fundType>PF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>J3</citizenshipOrOrganization>
        <soleVotingPower>4203689.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>4203689.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>4203689.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>17.0</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, Par Value $0.001 per share</securityTitle>
        <issuerName>Cosmos Health Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>5 AGIOU GEORGIOU, PILEA</com:street1>
          <com:street2>5 AGIOU GEORGIOU, PILEA</com:street2>
          <com:city>THESSALONIKI</com:city>
          <com:stateOrCountry>J3</com:stateOrCountry>
          <com:zipCode>55438</com:zipCode>
        </issuerPrincipalAddress>
      </item1>
      <item2>
        <filingPersonName>Grigorios Siokas</filingPersonName>
        <principalBusinessAddress>5AG Georgiou Str., Pilea, Thessaloniki J3TK 57001</principalBusinessAddress>
        <principalJob>CEO, Cosmos Health, Inc., 141 West Jackson Boulevard, Suite 4236, Chicago, IL 60604</principalJob>
        <hasBeenConvicted>No criminal proceedings to be disclosed</hasBeenConvicted>
        <convictionDescription>No civil proceedings to be disclosed</convictionDescription>
        <citizenship>Greece</citizenship>
      </item2>
      <item3>
        <fundsSource>Personal funds, none of which have been borrowed.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>There are no plans or proposals which the reporting person has which may result in any of the matters listed.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>4,203,689 (17%) shares based on 24,032,040 shares issued and outstanding on January 14, 2025.</percentageOfClassSecurities>
        <numberOfShares>Sole voting power and disposition power - 4,203,689 shares; includes 3,491,306 issued shares; 212,383 shares issuable upon exercise of Exchange Warrants issued on October 20, 2022, pursuant to a Warrant Exchange Agreement dated as of October 3, 2022; and 500,000 shares issuable upon exercise of Series B Common Warrants exercisable at $3.00 per share sold pursuant to Registration Statement No. 333-267917.</numberOfShares>
        <transactionDesc>On December 20, 2024, Mr. Siokas entered into a Debt Exchange Agreement pursuant to which he acquired 257,334 shares of common stock at an Exchange Rate of $0.5829 per share, or an aggregate of approximately $150,000, the fair market value of the Common Shares, in exchange for $150,000 the Company owed Mr. Siokas.

On January 13, 2025, Mr. Siokas entered into a Debt Exchange Agreement pursuant to which he acquired 163,666 shares of common stock at an Exchange Rate of $0.611 per share, or an aggregate of approximately $100,000, the fair market value of the Common Shares, in exchange for $100,000 the Company owed Mr. Siokas.

On January 14, 2025, Mr. Siokas entered into a Debt Exchange Agreement pursuant to which he acquired 87,247 shares of Common Stock at an Exchange Rate of $0.6877 per share, or an aggregate of approximately $60,000, the fair market value of the Common Shares, in exchange for $60,000 the Company owed Mr. Siokas.

On January 15, 2025, Mr. Siokas entered into a Debt Exchange Agreement pursuant to which he acquired 62,500 shares of Common Stock at an Exchange Rate of $0.80 per share, or an aggregate of approximately $50,000, the fair market value of the Common Shares, in exchange for $50,000 the Company owed Mr. Siokas.

On January 16, 2025 Mr. Siokas entered into a Debt Exchange Agreement pursuant to which he acquired 47,904 shares of common stock at an Exchange Rate of $0.835 per share, or an aggregate of approximately $40,000, the fair market value of the Common Shares, in exchange for $40,000 the Company owed Mr. Siokas.

On January 17, 2025, Mr. Siokas entered into a Debt Exchange Agreement pursuant to which he acquired 29,158 shares of Common Stock at an Exchange Rate of $0.8574 per share, or an aggregate of approximately $25,000, the fair market value of the Common Shares, in exchange for $25,000 the Company owed Mr. Siokas.

On January 22, 2025, Mr. Siokas entered into a Debt Exchange Agreement pursuant to which he acquired 38,900 shares of Common Stock at an Exchange Rate of $0.7712 per share, or an aggregate of approximately $30,000, the fair market value of the Common Shares, in exchange for $30,000 the Company owed Mr. Siokas.</transactionDesc>
        <listOfShareholders>No person has the right to receive, or the power to direct the receipt of dividends from, or proceeds from, the sale of such securities.</listOfShareholders>
        <date5PercentOwnership>Not applicable.</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>None</contractDescription>
      </item6>
      <item7>
        <filedExhibits>None</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Siokas Grigorios</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Grigorios Siokas</signature>
          <title>Grigorios Siokas/Chief Executive Officer</title>
          <date>01/29/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
